Clinical Trials Update

Featured News

All News

Filter by Categories
Clinical
Oncology
Pediatric Oncology
Uncategorized
Young Adult

Newly approved drug effective against lung cancer caused by genetic mutation

The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed to shut down the effects of the mutation, which is found in

Newly approved drug effective against lung cancer caused by genetic mutation

The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed to shut down the effects of the mutation, which is found in

Make a Referral

Refer a patient to a Washington University Physician at Siteman Cancer Center.

Clinical Trials

Search our online directory of open trials.

Physician Services

Contact our physician liaison team for more information about Siteman Cancer Center services, physicians and programs.

Subscribe to Our Newsletter

Receive the latest updates on Siteman Cancer Center services, physicians, educational programs and more.